$SRXH News

SRX Global Reports 26% Returns From Paper-Traded EMJX From Feb. 11 To July 10

SRX Global Authorizes $20M Share Buyback Program For Up To 10M Shares, Or 50% Of Outstanding Stock

SRX Global Estimates Net Asset Value Of $60M, Or $3.07 Per Share; Reports No Debt Outstanding, As Of June 30, 2026

Why SRX Global Shares Are Trading Lower On Wednesday

SRX Global Announces 60-To-1 Stock Consolidation, Effective July 6

SRx Health Solutions Launches AI-Driven Platform Strategy Under New Name SRX Global Following Completion Of EMJ Crypto Technologies Acquisition; To Allocate Capital Into High-Conviction Operating Companies And Assets

SRX HealthSolutions Q2 EPS $(0.02) Up From $(0.39) YoY, Sales $3.439M

SRx Health, EMJ Crypto Technologies Announce Investment Of Over 10% Of Investable Capital In Astro Investment

SRx Health Solutions And Merger Partner EMJ Crypto Technologies Invest In Astro Capital Special Purpose Vehicle

SRx Health Solutions And Merger Partner EMJ Crypto Technologies Issue Letter To Shareholders From EMJX Platform Creator Eric Jackson

SRx Health Solutions And EMJ Crypto Technologies Acquire Shares In Open Market Of Compass, Terms Undisclosed; Increase Investment In Opendoor Technologies

SRx Health Solutions And EMJ Crypto Technologies Hedge DeFi Portfolio With Investment In Gold, Also Reduced Its Hedge On Emerging Markets; No Terms Disclosed

SRx Health Solutions Enters Hedged Position On Its Cryptocurrency And Emerging Markets Investment Portfolio For Volatility Protection On Digital Assets And International Revenues; Size And Details Of Positioning Not Disclosed

SRx Health Solutions Enters Hedged Position On Its Cryptocurrency And Emerging Markets Investment Portfolio For Volatility Protection On Digital Assets And International Revenues; Size And Details Of Positioning Not Disclosed

SRx Health Solutions Announces Receipt of Warning Letter from NYSE American

SSRx Health Increases Holdings In Opendoor Technologies By 30%

SRx Health Solutions Receives Public Warning Letter From NYSE About Failure To Maintain Listing Compliance

SRX HealthSolutions Q1 EPS $(0.26) Down From $(0.17) YoY, Sales $2.807M

SRx Health Solutions Redeems Series A Preferred Stock and Cancels Approximately 125,000,000 Shares of Common Stock, Improving Balance Sheet Flexibility for Investment in M&A or Return of Capital to Shareholders

SRx Health Solutions Redeems 17.5K Series A Preferred Shares For $15.23M